In the recently published ‘A 3D printed microfluidic-enabled hollow microneedle architecture for transdermal drug delivery,’ researchers explore innovative methods for delivering medication into the bloodstream via the skin. In this study, they work on the micro-level to create ‘new degrees of freedom’ in delivery.
As medicine continues in the direction of patient-specific treatments, 3D printing continues to play an enormous role—including medical devices, implants, innovations in tissue engineering like scaffolding, and much more. In this study, the researchers continue to refine the use of needles for transdermal use.
Conventionally, they have been fabricated with materials like plastics, metals, ceramics, and more. With the advent of biocompatible polymers, microneedles are being more widely used due to greater disposability, affordability, and the potential for customization—pointing toward patient-specific benefits overall.
Microfluidic devices are behind many of the new capabilities in drug delivery systems, allowing for mixing and transporting of the required small amounts of fluids.
“For example, microfluidic mixing was used to directly synthesize nanoparticles with tunable physicochemical properties such as particle size, homogeneity, and drug loading and release at the point of delivery,” state the researchers. “Additionally, the combination of microneedles and microfluidic mixing is beneficial in areas such as combinational therapy-based subcutaneous/transdermal administration for preclinical testing of biologic treatments.”
New systems are being developed too for ‘codosing,’ allowing for patients to receive several medications at once. Microfluidics and innovative drug delivery systems make the process more affordable, simpler, and less open to error. This study yields microfluidic-enabled microneedle devices printed via single-step stereolithography (SLA) from an ‘elaborate hollow microneedle design,’ resulting in a refined microneedle array.
“This architecture allows the modulation of the input fluid solutions’ flow rates to facilitate programmable drug delivery in future combinational therapy-based applications,” stated the researchers.
While there are benefits to SLA 3D printing, the research team was tasked to refine the process further for this study, creating a new microneedle design and print set up.
The research team was able to create up to 12 devices (with dimensions of 1.5 × 1.2 × 3.1 cm) using class IIa biocompatible resin in a single print, in 2.5 hours.
Scanning microscopy displayed success in both design and 3D printing of the arrays.
“Penetration and fracture tests confirmed the microneedles’ mechanical robustness for practical application. An example microfluidic-enabled microneedle device was printed with our devised scheme that facilitates homogeneous mixing of multiple fluids under different flow rates, followed by transdermal delivery of the mixed solution. Comparisons of various flow rate ratios with colored dye solutions showed tunable control over the relative concentrations of solutes delivered. Ex vivo confocal laser scanning microscopy of three fluorochrome model-drug solutions on porcine skin further validated the platform’s ability for transdermal drug modulation and delivery,” concluded the researchers.
“This 3D printed device is particularly applicable to preclinical investigations centered on combinational drug therapy, where the in-situ combination of multiple drugs and the tuning of their physicochemical properties lead to more effective outcomes than single or premixed agents alone. For example, the controlled multifluidic synthesis of nanoparticles can tune the release mechanisms of various drugs for wound healing applications.”
What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.[Source / Images: ‘A 3D printed microfluidic-enabled hollow microneedle architecture for transdermal drug delivery’]
You May Also Like
Launcher’s New Orbital Transfer Vehicle to Rideshare on SpaceX Falcon 9 in 2022
Launcher’s new orbit transfer vehicle (OTV) will debut on a SpaceX Falcon 9 rideshare for its inaugural flight to Sun-synchronous orbit (SSO) in October 2022. Known as Launcher Orbiter, the...
SpaceX Successes Drive off-Earth Innovation, So Do Its Failures
After a highly anticipated test launch, SpaceX‘s Starship SN11 prototype finally lifted off for a planned test flight. Climbing up from out of the cloud deck at the company’s South...
From Magnets to Harpoons: How to Catch Space Debris
The world’s first commercial test mission to locate and remove space debris has finally launched to space. On March 22, 2021, Astroscale’s End-of-Life Services demonstration (ELSA-d) mission took off from...
Relativity Space Preparing for Next Year’s Rocket Launch with New VP and Verified 3D Printing Tech
In the last few years, there has been excitement for the new race to the moon. But as deadlines for rocket launches and crewed missions get closer, space companies begin...
View our broad assortment of in house and third party products.